Namita Thapar-backed Emcure Pharma IPO to fetch her 127 Cr on exit
Shark Tank's Namita Thapar, a member of Emcure Pharmaceuticals' promoter group, is poised to earn approximately Rs 127 crore through the upcoming IPO. Thapar acquired shares in Emcure at an average price of Rs 3.44 each and plans to sell around 12.68 lakh shares through the OFS component of the IPO. With the upper price band set at Rs 1,008 per share, the stake sale is expected to yield about Rs 127 crore.
Read more on
01:13- 02:50
- 07:10
- 03:28
- 02:04
- 01:35
- 03:17
- 02:04
- 01:52
- 02:37
- 01:50
- 01:42
- 05:00
- 04:34
- 02:26
- 02:32
- 01:42
- 03:10
- 01:14
- 30:28
- 00:47
- 04:44
- 05:42
- 02:16
- 07:02
- 02:40
- 03:10
- 01:52
HDFC AMC IPO to kick off on Wednesday
Views: 2010 - 06:19
- 01:02
- 00:33
- 02:33
- 02:12
- 01:56
- 05:01
- 01:28
- 02:34
- 00:26
- 03:31
- 03:10
